BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury

Bibliographic Details
Main Authors: Olivia J. Marola, Sarah E. R. Yablonski, Peter G. Shrager, Robert W. Nickells, Richard T. Libby
Format: Article
Language:English
Published: Nature Publishing Group 2022-07-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-022-01111-4
_version_ 1818192926373576704
author Olivia J. Marola
Sarah E. R. Yablonski
Peter G. Shrager
Robert W. Nickells
Richard T. Libby
author_facet Olivia J. Marola
Sarah E. R. Yablonski
Peter G. Shrager
Robert W. Nickells
Richard T. Libby
author_sort Olivia J. Marola
collection DOAJ
first_indexed 2024-12-12T00:38:16Z
format Article
id doaj.art-eb892c47a1154f999d3036c99161ddab
institution Directory Open Access Journal
issn 2058-7716
language English
last_indexed 2024-12-12T00:38:16Z
publishDate 2022-07-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj.art-eb892c47a1154f999d3036c99161ddab2022-12-22T00:44:19ZengNature Publishing GroupCell Death Discovery2058-77162022-07-01811410.1038/s41420-022-01111-4BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injuryOlivia J. Marola0Sarah E. R. Yablonski1Peter G. Shrager2Robert W. Nickells3Richard T. Libby4Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical CenterDepartment of Ophthalmology, Flaum Eye Institute, University of Rochester Medical CenterDepartment of Neuroscience, University of RochesterDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-MadisonDepartment of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Centerhttps://doi.org/10.1038/s41420-022-01111-4
spellingShingle Olivia J. Marola
Sarah E. R. Yablonski
Peter G. Shrager
Robert W. Nickells
Richard T. Libby
BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
Cell Death Discovery
title BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_full BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_fullStr BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_full_unstemmed BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_short BclX L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_sort bclx l bcl2l1 gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
url https://doi.org/10.1038/s41420-022-01111-4
work_keys_str_mv AT oliviajmarola bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT saraheryablonski bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT petergshrager bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT robertwnickells bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT richardtlibby bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury